AVP and myocardial infarction: Copeptin was proven to be a valuable sensitive biomarker in the diagnosis of acute coronary syndromes, as its levels were elevated in the early stages after the onset of an acute myocardial infarction, with a negative predictive value between 97% and 100% [132].